Change of joint company secretary, authorised representative and process agent
Filed with HKEX · Stock code 2190 · · 2 pages · English
Summary by 6ix AI
Zylox-Tonbridge Medical Technology Co., Ltd. has announced a change in its joint company secretary, authorised representative, and process agent. Ms. Kwan Sau In has resigned from these positions due to personal work arrangements, effective from a specified future date. Ms. Wong Ka Man has been appointed to fill these roles, bringing over eight years of corporate secretarial experience. The board expressed gratitude to Ms. Kwan for her contributions and welcomed Ms. Wong to her new position.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/change-of-joint-company-secretary-authorised-representative-and-process-agent-1
Zylox-Tonbridge Medical Technology Co., Ltd. on 6ix
Earlier from Zylox-Tonbridge Medical Technology
- Discloseable transaction in relation to the proposed acquisition of equity interest in the target company and the proposed issue of new h shares under the general mandate
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Next Day Disclosure Return
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Interim Report 2026
Follow Zylox-Tonbridge Medical Technology into a list and get an email when it puts out news.
Follow Zylox-Tonbridge Medical Technology